Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127049822 | 12704982 | 2 | F | 20160712 | 20160909 | 20160831 | 20160913 | EXP | CA-ABBVIE-16P-028-1713142-00 | ABBVIE | 28.70 | YR | F | Y | 50.39000 | KG | 20160913 | MD | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127049822 | 12704982 | 1 | PS | LUPRON DEPOT | LEUPROLIDE ACETATE | 1 | Intramuscular | Y | UNKNOWN | 20708 | 11.25 | MG | POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION | ||||||
| 127049822 | 12704982 | 2 | C | ESTRACE | ESTRADIOL | 1 | 0 | QOD | |||||||||||
| 127049822 | 12704982 | 3 | C | NORTYLINE | 2 | Unknown | 0 | QOD | |||||||||||
| 127049822 | 12704982 | 4 | C | NAPROXEN. | NAPROXEN | 1 | Oral | UNKNOWN | 0 | ||||||||||
| 127049822 | 12704982 | 5 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | Unknown | 0 | 50 | MG | QD | ||||||||
| 127049822 | 12704982 | 6 | C | TYLENOL WITH CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Unknown | 1 TO 2 TABLETS | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127049822 | 12704982 | 1 | Endometriosis |
| 127049822 | 12704982 | 2 | Product used for unknown indication |
| 127049822 | 12704982 | 3 | Product used for unknown indication |
| 127049822 | 12704982 | 4 | Product used for unknown indication |
| 127049822 | 12704982 | 5 | Product used for unknown indication |
| 127049822 | 12704982 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127049822 | 12704982 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127049822 | 12704982 | Bone density decreased | |
| 127049822 | 12704982 | Bone disorder | |
| 127049822 | 12704982 | Emotional disorder | |
| 127049822 | 12704982 | Hot flush | |
| 127049822 | 12704982 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127049822 | 12704982 | 1 | 20150925 | 20160621 | 0 |